While China Pharma Holdings Inc. has overperformed by 10.96%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CPHI fell by -88.33%, with highs and lows ranging from $0.80 to $0.07, whereas the simple moving average fell by -57.18% in the last 200 days.
On January 08, 2010, Rodman & Renshaw started tracking China Pharma Holdings Inc. (AMEX: CPHI) recommending Mkt Outperform.
Analysis of China Pharma Holdings Inc. (CPHI)
Further, the quarter-over-quarter decrease in sales is -8.26%, showing a negative trend in the upcoming months.
China Pharma Holdings Inc.’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -69.55% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.29, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and CPHI has an average volume of 2.01M. On a monthly basis, the volatility of the stock is set at 10.51%, whereas on a weekly basis, it is put at 11.96%, with a loss of -7.95% over the past seven days.
How Do You Analyze China Pharma Holdings Inc. Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 62.34%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 1.07% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
CPHI shares are owned by institutional investors to the tune of 1.07% at present.
